<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

How will blockchain impact life sciences?

What do the life sciences have to do with blockchain? The word tends to sti...

Read More

How can a market be both overheated and underinves...

As the saying goes, “Data doesn’t lie…”, except sometimes it does mislead. ...

Read More

Infographic: LSX Investor Perception Survey 2019

Now in its third year, the LSX Investor Perception Survey 2019 tracks the v...

Read More

Life science investors reveal their investment pre...

Around two thirds (61%) of life science investor respondents look for manag...

Read More

The Future of Digital Health: Q&A with Capricorn V...

As new technologies look to play an ever-increasing role in addressing heal...

Read More

LSX World Congress 2019 fast approaches

On 5-6 February 2019, international life sciences investors, C-level execut...

Read More

Transforming health and social care: industry pers...

At a roundtable event in London in September 2018, CMS assembled a selectio...

Read More

Life science leaders to address strategic company ...

Senior executives and investors in the life sciences sector will convene in...

Read More

World-first accreditation to out-of-this-world app...

Key learnings: Oxford-based Oxehealth has secured medical device accreditat...

Read More

AI update: medical software and pre-emption

In light of the rapidly expanding field of medical software technology, and...

Read More

Artificial intelligence and machine learning in he...

Artificial intelligence (AI), particularly machine learning (ML), is alread...

Read More

Infographic: C-suite challenges in life sciences 2...

In early 2017, LSX, formerly Biotech and Money, published the inaugural Inv...

Read More

Add Your Response